http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020120739-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff4c5d1070f93bc73c74f90211c12705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e57ed4ced13bac0de290700592384bee |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5685 |
| filingDate | 2019-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de8a41856c9f62747c3910334a8e2dcb |
| publicationDate | 2020-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2020120739-A1 |
| titleOfInvention | MEDICATION AGAINST ESTROGEN-RECEPTOR ß (ERß) POSITIVE BREAST TUMOR |
| abstract | The present invention relates to the field of medicine, and refers to the steroid compound 4-hydroxyandrost-4-ene-3, 17-dione (4-OHA) or ester thereof, as a prodrug for use in the treatment of a patient suffering from estrogen-receptor β (ERβ) positive breast tumour. The present invention further relates to a pharmaceutical composition comprising said steroid compound for topical application, and the use of said steroid compound in a pre-surgical topical treatment of ERβ-positive breast cancer tissue. |
| priorityDate | 2018-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 269.